LINC02348

Across TCGA pan-cancer cohorts, LINC02348 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated LINC02348 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher LINC02348 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC02348 expression acts as an unfavorable survival marker, although some lineages such as KIRC and LGG show a favorable association.

KIRC, COAD, and DLBC are the cancer types where LINC02348 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Median	All	0.709	0.549	<.001	116	view →
COAD	OS	Tertile	All	0.448	0.656	<.001	113	view →
DLBC	OS	Tertile	II,III,IV	0.172	0.949	<.001	84	view →
LGG	OS	Median	All	0.933	0.855	<.001	30	view →
ACC	DFS	Tertile	All	0.391	0.795	.009	24	view →
CHOL	OS	Tertile	II,III,IV	0.019	0.765	.001	21	view →
PAAD	OS	Quartile	II,III,IV	0.384	0.613	.008	20	view →
READ	DFS	Tertile	IV	0.096	0.645	<.001	18	view →
CESC	DFS	Tertile	II,III,IV	0.295	0.598	.018	16	view →
LIHC	OS	Tertile	All	0.676	0.887	.009	15	view →
LUAD	OS	Median	III,IV	0.600	0.425	.024	12	view →
UCEC	DFS	Tertile	All	0.863	0.912	.040	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

LINC02348–KIRC (DFS)

Open the KIRC breakdown →